Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.
| Distributed by / for | American Pharmaceutical Ingredients LLC |
| NDC | 58597-8632-6 |
| Full product label | Duloxetine HCl USP for prescription compounding, packaged in a)100g (NDC 58597-8632-6); b)1000 g (NDC 58597-8632-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327 |
| Recalling firm | American Pharmaceutical Ingredients LLC |
| Distribution | Nationwide within USA. |
| Quantity | 10000 g |
| Recall initiated | 2018-02-09 |
| Report date | 2018-02-28 |
| Recall completed | 2019-12-02 |
| Recall number | D-0487-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Waterford MI United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗